Recent Advances in Anti-Cancer Drugs, 2nd Edition
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 September 2025 | Viewed by 55
Special Issue Editor
Interests: targeted cancer therapy; apoptosis; metastasis; cancer chemoresistance; pancreatic cancer; breast cancer; lung cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is a pleasure for me to invite you to contribute to this Special Issue in IJMS that aims to collect the latest information on a wide variety of novel anti-cancer therapies. Despite all the advances of the last decades, many challenges remain in targeting aggressive and resistant cancer. The design of new drugs or improvement of current therapies remains at the forefront of cancer research. In addition, identifying the underlying causes of cancer chemoresistance as well as the discovery of biomarkers that predict patient response to treatment are pivotal for enhancing therapeutic efficacy.
In this Special Issue, we aim to report the latest developments on anti-cancer therapy, with special emphasis on targeting difficult-to-treat cancers, including but not limited to triple negative breast cancer, lung, pancreatic cancer and glioblastoma. Efforts to evaluate the efficacy of anti-cancer drugs and reverse chemoresistance in the pre-clinical setting will also be included. Potential contributors are invited to submit papers on the following topics:
- Synergistic anti-cancer therapy, especially involving small-molecule inhibitors and agents derived from natural sources;
- Therapeutic approaches to reverse cancer chemoresistance as well as identification of underlying mechanisms of resistance;
- Recent developments in immunotherapy;
- Predictive biomarkers, especially derived from liquid biopsies, to determine therapeutic efficacy;
- Anti-cancer drugs targeting metastatic dormancy;
- Agents that modulate the tumor microenvironment for improving therapeutic efficacy;
- Modern approaches in preclinical drug discovery including 3D culture systems.
Experimental studies using in vitro and in vivo models and review articles are all welcome for consideration.
Dr. Christiana Neophytou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- combination therapy in cancer
- small-molecule inhibitors in cancer
- anti-cancer agents derived from natural sources
- immunotherapy advances in cancer therapy
- targeting metastatic dormancy
- modulation of the tumor microenvironment
- 3D model approaches in cancer research
- predictive biomarkers for cancer chemoresistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
